Flash-Player installieren
ScheBo-MediaBox



» Flash-Player installieren
ScheBo® Biotech AG
Netanyastrasse 3
35394 Giessen, Germany


Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
Email-contact

ScheBo® M2-PK Quick™ -Test

Rapid Test for detecting colorectal and other gastrointestinal tumors for all medical services

The ScheBo® M2-PK Quick™ stool test is a visual immunochromatographic rapid test for detecting M2-PK in stool samples. It is an in-vitro diagnostic test exclusively for professional use. The test is used for colorectal cancer screening and indicates colorectal polyps, colorectal cancer, acute and chronic inflammatory bowel disease and other diseases of the digestive tract. The test result is not affected by any foods, so no dietary restrictions are necessary before taking the stool sample. It does not measure blood in the stool but instead it recognizes the enzyme M2-PK (M2-pyruvate kinase).

The ScheBo® M2-PK Quick™ stool test can detect bleeding and non-bleeding colorectal polyps and tumors and has significantly superior sensitivity compared to conventional occult blood tests. M2-PKQuick™ has 94% sensitivity and 96% specificity when compared with the M2-PK ELISA.

The new rapid test is available since October 2007 and can be used by all physicians in private practise and hospitals. With the ScheBo® M2-PK Quick™ stool test the stool samples can be analysed in only a few minutes for the enzyme M2-PK.




A Decade of UK Success for Schebo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro diagnostic tests for the healthcare sector, has just celebrated its 10th Anniversary.
more...
A superior alternative for PLT users: Faecal Pancreatic Elastase Test
Pfizer recommends this test in a letter it sent to pharmacists notifying them about the withdrawal of PLT.
more...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
more...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
more...
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
Fecal tumor M2-PK is an appropriately sensitve tool to pre-select those patients requiring colonoscopy for the further diagnostic confirmation or exclusion of colorectal cancer.
more...
ISO-Certificate
Our ISO-Cerficate as pdf-download.
more...